- Home
- CBFV vs KRRO Comparison
CBFV vs KRRO Comparison
Compare CBFV & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBFV | KRRO |
|---|---|---|
| Founded | 1901 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.9M | 187.9M |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CBFV | KRRO |
|---|---|---|
| Price | $37.87 | $10.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 12 |
| Target Price | ★ $38.00 | $34.80 |
| AVG Volume (30 Days) | 2.5K | ★ 151.2K |
| Earning Date | 04-22-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.54 | N/A |
| Revenue | ★ $43,557,000.00 | $6,392,000.00 |
| Revenue This Year | $48.93 | N/A |
| Revenue Next Year | $7.97 | N/A |
| P/E Ratio | $23.95 | ★ N/A |
| Revenue Growth | N/A | ★ 181.46 |
| 52 Week Low | $30.97 | $5.20 |
| 52 Week High | $38.86 | $55.89 |
Technical Indicators
Market Signals| Indicator | CBFV | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 36.51 |
| Support Level | $36.88 | $10.40 |
| Resistance Level | $37.78 | $14.51 |
| Average True Range (ATR) | 0.43 | 1.29 |
| MACD | -0.06 | -0.36 |
| Stochastic Oscillator | 38.46 | 16.39 |
Price Performance
Historical ComparisonAbout CBFV CB Financial Services Inc.
CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.